International Journal of Antimicrobial Agents
Volume 36, Issue 2 , Pages 145-150 , August 2010

Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseria gonorrhoeae

  • Hencelyn Chu

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA
    • ,
  • Anatoly Slepenkin

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA
    • ,
  • Mikael Elofsson

      Affiliations

    • Department of Chemistry, Umeå University, Sweden
    • ,
  • Pia Keyser

      Affiliations

    • Creative Antibiotics Sweden AB, Umeå, Sweden
    • ,
  • Luis M. de la Maza

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA
    • ,
  • Ellena M. Peterson

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA
    • Corresponding Author InformationCorresponding author. Present address: Department of Pathology and Laboratory Medicine, Medical Science Building, Room D-440, University of California–Irvine, Irvine, CA 92697-4800, USA. Tel.: +1 949 824 4169; fax: +1 949 824 2160.

Received 5 December 2009 ,Accepted 9 March 2010.

References 

  1. Joyee AG, Thyagarajan SP, Reddy EV, Venkatesan C, Ganapathy M. Genital chlamydial infection in STD patients: its relation to HIV infection. Indian J Med Microbiol. 2005;23:37–40
  2. Nusbaum MR, Wallace RR, Slatt LM, Kondrad EC. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus. J Am Osteopath Assoc. 2004;104:527–535
  3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3–17
  4. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73–83
  5. Kapiga SH, Sam NE, Bang H, Ni Q, Ao TT, Kiwelu I, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis. 2007;195:1260–1269
  6. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993;7:95–102
  7. Van Damme L. Clinical microbicide research: an overview. Trop Med Int Health. 2004;9:1290–1296
  8. Howett MK, Kuhl JP. Microbicides for prevention of transmission of sexually transmitted diseases. Curr Pharm Des. 2005;11:3731–3746
  9. Klasse PJ, Shattock R, Moore JP. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu Rev Med. 2008;59:455–471
  10. Vallely A, Kasindi S, Hambleton IR, Knight L, Chirwa T, Balira R, et al. Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months. Sex Transm Dis. 2007;34:638–643
  11. Harrison PF, Rosenberg Z, Bowcut J. Topical microbicides for disease prevention: status and challenges. Clin Infect Dis. 2003;36:1290–1294
  12. Cone RA, Hoen T, Wong X, Abusuwwa R, Anderson DJ, Moench TR. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis. 2006;6:90
  13. Slepenkin A, Enquist PA, Hagglund U, de la Maza LM, Elofsson M, Peterson EM. Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun. 2007;75:3478–3489
  14. Anderson JE, Hobbs MM, Biswas GD, Sparling PF. Opposing selective forces for expression of the gonococcal lactoferrin receptor. Mol Microbiol. 2003;48:1325–1337
  15. Biswas GD, Anderson JE, Chen CJ, Cornelissen CN, Sparling PF. Identification and functional characterization of the Neisseria gonorrhoeae lbpB gene product. Infect Immun. 1999;67:455–459
  16. Peterson EM, Zhong GM, Carlson E, de la Maza LM. Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity. Infect Immun. 1988;56:885–891
  17. Fanizza C, Ursini CL, Paba E, Ciervo A, Di Francesco A, Maiello R, et al. Cytotoxicity and DNA-damage in human lung epithelial cells exposed to respirable α-quartz. Toxicol In Vitro. 2007;21:586–594
  18. Suchland RJ, Geisler WM, Stamm WE. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.. Antimicrob Agents Chemother. 2003;47:636–642
  19. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonák J, Lind K, et al. The real-time polymerase chain reaction. Mol Aspects Med. 2006;27:95–125
  20. Peterson EM, You JZ, Motin V, de la Maza LM. Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal challenge with the homologous serovar. Vaccine. 1999;17:2901–2907
  21. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS. 1996;10(Suppl. 3):S43–S51
  22. Grant RM, Hamer D, Hope T, Johnston R, Lange J, Lederman MM, et al. Whither or wither microbicides?. Science. 2008;321:532–534
  23. Wilson DP, Coplan PM, Wainberg MA, Blower SM. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc Natl Acad Sci USA. 2008;105:9835–9840
  24. Kontoghiorghes GJ, Weinberg ED. Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches. Blood Rev. 1995;9:33–45
  25. Nordfelth R, Kauppi AM, Norberg HA, Wolf-Watz H, Elofsson M. Small-molecule inhibitors specifically targeting type III secretion. Infect Immun. 2005;73:3104–3114
  26. Keyser P, Elofsson M, Rosell S, Wolf-Watz H. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. J Intern Med. 2008;264:17–29
  27. Kauppi AM, Andersson CD, Norberg HA, Sundin C, Linusson A, Elofsson M. Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides. Bioorg Med Chem. 2007;15:6994–7011
  28. Dill BD, Dessus-Babus S, Raulston JE. Identification of iron-responsive proteins expressed by Chlamydia trachomatis reticulate bodies during intracellular growth. Microbiology. 2009;155:210–219
  29. Dill BD, Raulston JE. Examination of an inducible expression system for limiting iron availability during Chlamydia trachomatis infection. Microbes Infect. 2007;9:947–953
  30. Nieuwenhuis RF, Ossewaarde JM, Götz HM, Dees J, Thio HB, Thomeer MG, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis. 2004;39:996–1003
  31. Nieuwenhuis RF, Ossewaarde JM, van der Meijden WI, Neumann HA. Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1g azithromycin. Sex Transm Infect. 2003;79:453–455
  32. Noto JM, Cornelissen CN. Identification of TbpA required for transferrin-iron utilization by Neisseria gonorrhoeae. Infect Immun. 2008;76:1960–1969
  33. Jerse AE, Crow ET, Bordner AN, Rahman I, Cornelissen CN, Moench TR, et al. Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal lactobacilli. Infect Immun. 2002;70:2549–2558
  34. Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis. 2001;184:1431–1436
  35. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989;27:251–256
  36. Hill GB, Eschenbach DA, Holmes KK. Bacteriology of the vagina. Scand J Urol Nephrol Suppl. 1984;86:23–39
  37. Imbert M, Blondeau R. On the iron requirement of lactobacilli grown in chemically defined medium. Curr Microbiol. 1998;37:64–66

PII: S0924-8579(10)00151-2

doi: 10.1016/j.ijantimicag.2010.03.018

International Journal of Antimicrobial Agents
Volume 36, Issue 2 , Pages 145-150 , August 2010

Article Tools

* Image Usage & Resolution